By Lewis Krauskopf
NEW YORK — U.S. stock indexes finished with their strongest monthly performances in four years Friday, even as they fell for the day amid a mixed bag of earnings reports.
For October, all three major indexes posted their biggest percentage increases since October 2011, with the SP 500 rising 8.3 percent, led by energy and materials, while a measure of volatility fell.
On Friday, CVS Health (CVS) fell 4.8 percent to $98.78 after a disappointing profit forecast for 2016.
It would be nice to have some clarity once and for all of what monetary policy is going to do over the foreseeable future.
Investors will be looking at data over the next several weeks, including next Friday’s employment report, for clues about the economy’s health. The Fed signaled Wednesday a rate hike in December was still possible.
“The market is being held a little bit hostage,” said Jeff Buetow, chief investment officer at Innealta Capital in Austin. “It would be nice to have some clarity once and for all of what monetary policy is going to do over the foreseeable future.”
The Dow Jones industrial average (^DJI) fell 92.26 points, or 0.5 percent, to 17,663.54, the Standard Poor’s 500 index (^GSPC) lost 10.05 points, or 0.5 percent, to 2,079.36 and the Nasdaq composite (^IXIC) dropped 20.53 points, or 0.4 percent, to 5,053.75.
For the month, the Dow gained 8.5 percent, while the Nasdaq rose 9.4 percent.
In a signal of a return to calm in markets, the CBOE volatility index fell 38.5 percent in October – its largest monthly percentage decline on record.
“We’re not likely to see another month like this anytime soon,” said Marshall Gause, chief executive of Geneva Fund Partners in Denver. “This month was a rebound off the lows.”
For the week, the Dow inched up 0.1 percent, the SP increased 0.2 percent, and the Nasdaq rose 0.4 percent. The SP posted its fifth straight week of gains, its longest such streak this year.
Winners and Losers
The SP health care sector index rose 3.1 percent for the week, the best weekly gain since March, spurred by strong pharmaceutical earnings.
Shares of drugmaker AbbVie (ABBV) jumped 10.1 percent Friday to $59.55, the biggest positive driver for the SP 500 index, after better-than-expected profit and a strong long-term outlook.
Consumer staples slipped 1.1 percent. U.S. consumer spending barely rose in September and the University of Michigan’s index on consumer sentiment came in below expectations.
The SP financial sector index fell 1.4 percent, with Genworth Financial (GNW) tumbling 10.3 percent to $4.68 after results.
U.S.-listed shares of Valeant Pharmaceuticals (VRX) dropped 15.9 percent to $93.77, its lowest since July 2013, after cutting all ties with specialty pharmacy Philidor.
NYSE advancing issues outnumbered declining ones 1,647 to 1,404, for a 1.17-to-1 ratio; on the Nasdaq, 1,638 issues fell and 1,161 advanced, for a 1.41-to-1 ratio favoring decliners.
The SP 500 posted 18 new 52-week highs and 4 lows; the Nasdaq recorded 49 new highs and 78 lows.
About 7.4 billion shares changed hands on U.S. exchanges, above the 7.1 billion average for the past 20 trading days, according to Thomson Reuters (TRI) data.
–Caroline Valetkevitch and Rodrigo Campos contributed reporting from New York; Abhiram Nandakumar contributed reporting from Bangalore, India.
What to Watch Monday:
- At 10 a.m., the Institute for Supply Management releases its manufacturing index for October, and the Commerce Department releases construction spending for September.
These selected companies are scheduled to report quarterly financial results: